I. The Characteristics of the Model
When analyzing the R & D behavior of a group of firms in which substantially different scales of operation exist, research intensity, rather than the absolute level of a firm's expenditures, is a more appropriate dependent variable. When absolute figures are used, heteroscedasticity is invariably present, and scale effects tend to dominate the regression equations. In order to avoid these problems, the procedure adopted in this paper is to measure R & D expenditures as well as size-correlated independent variables, relative to the total sales of the firm.4 Although there are some good a priori reasons for choosing sales as the particular size deflator,5 the 2 Of the six NSF industry classifications performing approximately $300 million or more of company-financed R & D in 1963, government supported R & D was over 25 per cent of total expenditures except in chemicals and allied products and. in petroleum refining. In these two industries it amounted to 21 per cent and 6 per cent, respectively.
3 The NSF definitions of R & D are given in the technical notes of all its published data reviews. These data have definite advantages over company published figures in that (1) they are based on a common externally devised definition; and (2) firms are assured of confidential treatment, thereby removing any incentives to inflate the figures artificially. While the NSF data are undoubtedly the best available statistics, it must be emphasized there are still many difficult conceptual problems in measuring inventive efforts by dollar outlays. See the discussions in Kuznets (1962) and Sanders (1962) . 4 An alternative approach for dealing with heteroscedasticity is to estimate the equations using logarithmic transformations when the specifications of the models permit one to do so. Both procedures have been extensively used in dealing with samples that are cross-sectional in nature and span a large size spectrum. For a discussion of the problem associated with using the ratio approach, see Kuh and Meyer (1955) . 5 This question has been analyzed by Scherer (1965b, pp. 256-61) in a commentary on some results of Hamberg (1964) . Among the reasons for choosing sales are: (1) sales is a more neutral size measure, and (2) firms have emphasized the use of sales as a landmark for budget decisions in various interview studies. results are substantially unaltered if either total assets or the number of employees is used instead.
The determinants of research intensity to be considered first relate to the returns from R & D activity. Since there is a considerable lag in the payoff to R & D, a firm's estimated set of returns from current projects will likely depend on its past results. While expectations based on past performance may not vary markedly from one budget period to the next for an individual firm, substantial variations should exist across firms due to the cumulated effects of past differences in firm capacities and attitudes toward R & D. The first explanatory variable of research intensity is, therefore, an index of the research productivity of each firm over a prior period.
In order to construct such a proxy variable of research productivity, three possible measures of a firm's research output were considered: newproduct sales, the number of patents granted to the firm, and the number of significant inventions made by the firm. Given the strong product orientation of industrial R & D, perhaps the best measure of the three from a conceptual standpoint is new-product sales. Unfortunately, newproduct sales are not generally available, and furthermore, substantial differences in definitions and product classification among firms make the use of these numbers in a cross-section analysis quite hazardous. Of the two other measures of research output, patents is the more attractive, since all patented inventions must pass certain uniform criteria of the U.S. Patent Office, and patent statistics are readily available.6
The measure of research outputs used in the model is, therefore, the number of patents granted to a firm in a specified prior period. To form the productivity variable, this output measure is divided by a researchinput measure-specifically, the number of scientists and engineers employed by the firm over the approximate period when the patented inventions were conceived.7 The first hypothesis put forth here is thus that firms with higher patented output per scientific worker in the past will, ceterisparibus, be more research-intensive than their rivals.8 Of course, this 6 Attempts at constructing a series of significant inventions made by each firm were beset by serious methodological problems and therefore discarded. For some interesting attempts to measure inventive output in this manner, see Mansfield (1964, pp. 334-37) .
7 Scherer (1965a, p. 1097) has estimated that over a period somewhat coincident with our sample the patent office took an average of three and one-half years to process a patent. Adding several more months as time necessary to draw up a patent application, the "patent lag" is taken somewhat arbitrarily here to be four years in length. 8 This relationship is likely to operate in a forward as well as backward manner. That is, more research-intensive firms now should realize a higher level of patented outputs in the future. There is ample evidence that firm behavior often follows such recursive patterns. While firms may certainly radically change past modes of operation, R & D in particular is not an activity that lends itself to frequent and marked changes in emphasis.
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variable at best measures only one aspect of the firm's returns from R & D -the technical quality of its research outputs. Another aspect, relating to the applicability of R & D to the firm's operations, will be considered below.
Before discussing the other explanatory variables, however, it should be mentioned that patents have been used elsewhere as a measure of inventive output, and their limitations in this regard have been extensively discussed (Kuznets, 1962; Sanders, 1962) . One of the more serious problems incurred in using patent statistics is the possibility that the propensity to patent might be systematically correlated in a positive way with a firm's degree of research intensity. If this were so, a spurious positive relation between research intensity and patent output per worker would result. However, there are no strong a priori arguments why this will be the case, and some data are available to analyze this question for the firms under study. This problem will be taken up in the next section.
The second explanatory variable of research intensity in the present model is an index of each firm's output diversification. It has been postulated in the literature (see Nelson, 1959 ) that a firm's degree of diversification will positively influence its profit expectations from R & D. This hypothesis follows from the belief that a more diversified firm will be better able to exploit unexpected research outputs than one with a narrower base of operations. While the original formulation was meant to apply to scientific work at the research end of the spectrum rather than to development expenditures, this hypothesis also implies greater expenditures on total R & D unless these two component activities are complete substitutes, which is highly unlikely.
The index of diversification used in the present mc-el is based on the number of separate five-digit SIC product classifications in which a firm produced during a middle year of the sample period.9 This variable, like the index of past research productivity, is designed to capture interfirm differences in expected returns from R & D. It therefore varies only over the cross-section of firms and not over time. Over a four-year interval, the size of the firm's product mix does not change significantly, and the 9 All the data on diversification come from the 1961 edition of the Fortune Plant and Product Directory. For the chemical and petroleum industries, an examination of the various product classes revealed that they are virtually all of sufficient technical character to have at least some potential relevance to the R & D activity. For these two industries, the index will therefore be the total number of separate SIC classifications encompassed by the firm's product mix. For the drug industry, however, product mixes of highly diversified drug firms indicate a tendency for them to expand into products only tangentially related to the manufacture of drugs proper (that is, adhesives, brushes, glass bottles, toilet preparations, plastic products, and so forth). These product lines offer little opportunity for the applicability of research outputs. It was therefore decided that a more appropriate index of diversification for the drug industry would be obtained by counting only the number of SIC classifications that are concerned directly with the manufacture of drugs proper. 
II. The Empirical Results
Using the data samples described above, least-squares estimates of the coefficients of equation (1) sample adhere to an industry-wide R & D to sales ratio. The only statistically significant intercept is negative (the drug industry), and the positive coefficients for the other two industries were negligible in value.1" The above regression results indicate that interfirm differences in technology, diversification, and the availability of funds all are important in explaining differences in research intensity with no single factor having a dominant influence. Table 1 also shows that the size of the regression coefficient associated with each of these variables increases with the research orientation of the industry involved-being the lowest in the petroleum industry and the highest in the drug industry in every case. Thus, as research looms more important as a competitive strategy to the firms of an industry, each of our independent variables exerts a correspondingly greater effect on the level of research that a firm performs.
11 All of the results presented in Table 1 are substantially unchanged when the profit component of the available funds variable is measured by the firm's retained earnings rather than its total after-tax profits. The results on the significance of the variables are the same, and the fit of the regression becomes slightly better for chemicals (R2 = .67) and slightly poorer for drugs (R2 = .80).
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The much poorer performance of the model in explaining research intensity in petroleum refining can be traced in part to certain structural factors that distinguish it from chemicals and drugs. Among these factors are: (1) R & D is much more process oriented in petroleum refining;12 (2) the degree of integration within this industry is very uniform, and the amount of outward diversification is slight; and (3) R & D is more of a peripheral activity, consuming a portion of the budget which is at least an order of magnitude smaller than in the other two industries. In an industry where research is process oriented, patents will likely be a poorer measure of technological output because firms will often wish to keep knowledge of such inventive activity concealed from their competitors. Furthermore, where R & D is a competitive strategy of lesser importance, as in petroleum refining, allocations to it tend to be more vulnerable to fluctuations in other uses of scarce funds. While there is no way to quantify the effects of the above three structural factors, together they probably explain a substantial part of the poorer performance of the model in this industry.
The positive relation observed between patented output per research input and the research intensity of a firm has been interpreted above as a measure of the effects of interfirm technology differences in research intensity. If it were true that more research-intensive firms have a greater propensity to patent than less intensive ones, this interpretation would be open to serious question. To investigate this latter possibility, data on the number of in-house patent attorneys for all the firms in our sample over the period 1955-59 were obtained. This is the most meaningful measure of patent activity available, although it is far from a complete index of it.13
Utilizing these data on patent attorneys, the correlation coefficient between a firm's research intensity and the number of in-house attorneys engaged per scientist and engineer was calculated for each of the three industry samples. Since the regression estimates have shown a significant relation between a firm's research intensity and the number of patents granted to it per research employee, one would also expect a significant relation between this variable and the number of in-house patent attorneys 12 The fifteenth annual McGraw-Hill Survey of Business for 1962 indicated that R & D planned by petroleum firms for that year was 42 per cent process oriented and only 6 per cent so in the chemical and allied products industries. In addition, the 1960 survey showed that new-product sales amounted to 16 per cent of total sales in the latter industry, while constituting only 2 per cent of total sales in the petroleum industry. 13 The crucial factor here is the relation of in-house patent attorneys to those hired from outside the firm. No statistics are available at present on the latter variable. The use of in-house attorneys by the firms in our sample was, however, quite extensive -almost all firms had at least one attorney, and most had several. In addition, the number of patent attorneys was well correlated with the number of patents (r = .7).
per research employee if this relation were merely the result of more research-intensive firms having a greater propensity to patent. The resulting correlation coefficient between these variables, however, is -.2 in chemicals, .1 in drugs, and .3 in petroleum. These correlations, none of which is significantly positive at the 5 per cent level, do not support the hypothesis that more research-intensive firms tend to patent a greater proportion of patentable inventions. Although this is admittedly a rather slim reed of evidence, it is all that is currently available. However, since there is no strong a priori case for any kind of correlation, it may be tentatively accepted as support for the position that no systematic relations exist between these variables. 
III. Research Intensity and Firm Size
All of the independent variables used in the above model-research productivity, the degree of internal liquidity, and diversification-have been cited in the literature as firm attributes positively associated with large size. It has been argued, therefore, that the large firms in a given 14 In addition to the accelerator term discussed in the text, some variables relating to external conditions in financial markets and to the financial position of the firm (that is, the interest rate, the size of the firm's external debt, and the debt-equity ratio) were also included, but these all proved to be very insignificant. . 333-37) , for example, found a significantly positive relation between research intensity and firm size in chemicals, whereas the drug and petroleum industries exhibited significantly negative ones. Since the variables supposedly underlying the Schumpeterian hypothesis yielded very good fits of research intensity in the chemical and drug industries-and yet these two industries apparently exhibit quite different structural relationships between research intensity and firm size-it is worth investigating the potential source of these differences.
First of all, in order to investigate the Schumpeterian hypothesis for the particular industrial samples under study, the following regression is estimated:
Si't Si't which in non-ratio form is the quadratic:
A quadratic estimated in the above fashion should indicate whether there is any tendency for research intensity to increase or diminish significantly as size increases through the behavior of the a2 coefficient. The regression estimates of equation (2) for the chemical and drug industries are presented in the top of Table 2 .16 While a, is positive and statistically significant as expected in both cases, the estimate of a2 is significantly positive for chemicals and significantly negative for drugs.17 A plot of these estimated relations is given in Figure 1 . It indicates that, for the drug industry, research intensity initially increases with firm size but is characterized by a decreasing relation for most of the relevant range. For the chemical industry, the estimated relation indicates that research intensity increases 16 The petroleum industry could also be included here, but it is omitted because the independent variables of equation (1) explained only one-third of the total variance for that industry. If one repeats the procedures described in this section for it, however, the interpretation of the results are consistent with those presented for chemicals and drugs. For the details, see Grabowski (1966, pp. 75-83) . 17 It may be noted that while the R2's are quite modest for this regression equation, the standard errors of estimate indicate quite good fits to the data. This, of course, is because, in the ratio form of estimating equation (3), much of the explanatory power now comes from the intercept term a, which affects the goodness of fit of equation (2) but not the R2; that is, the estimates of equation (2) 19 A qualification to the interpretation of the results obtained here and in the studies cited above arises from the fact that total firm sales is used as the independent variable rather than sales only in the particular three-digit industry for which the firm produces its principal products. Now, if it is the case that the nature of firm products in each of these industries varies significantly with size, then the above relationships may be due principally to this phenomenon rather than to any scale effects, such as those postulated above. As indicated earlier (see n. 9 above), the large firms in the drug industry do tend to expand and diversify into non-pharmaceutical areas where the opportunities for R & D applications are low. It is therefore very desirable to estimate equation (2) using only pharmaceutical sales for each firm. Until the required data are available, however, the present approach must be used in such studies and, accordingly, is quite tentative in nature. any real support for this position.20 With regard to the other two determinants, the internally generated funds and diversification variables are significantly positive in the chemical industry, which exhibited a positive structural relation with size. However, in drugs, where the relation was negative, the internally generated funds variable is significantly negatively correlated with size, and diversification exhibits a positive but insignificant correlation coefficient. Thus, the results suggest that the difference in the observed relation between research intensity and firm size in the two industries is due primarily to the flow of funds variable and, to a lesser extent, the diversification index. In the current analysis, it has been assumed that the significant relation between research intensity and firm size follows from the size behavior of the underlying independent variables specified in the model. An alternative interpretation is that size is the relevant determinant variable and that the significance of these explanatory variables of the model is spurious, arising from their mutual correlation with size. In order to investigate this alternative hypothesis, a further regression equation was estimated. This involved adding the two significantly size-correlated variables, diversification and the measure of cash flow, to equation (2) and observing the behavior of the previously estimated coefficients between R & D and the size of the firm. As shown in the lower half of Table 2 , when these two new variables are present, the a, and a2 coefficients lose their statistical significance in both industries. On the other hand, the estimates associated with the two determinant variables, a3 and a4, are significant, as in Table 1 . These results are thus consistent with the general interpretation of the regression estimates presented in this paper and not with the alternative hypothesis advanced above.
In summary, the analysis here indicates that there is no basis for the presumption that larger firms will necessarily possess the characteristics that promote a high degree of research intensity. Therefore, it is not surprising that tests of the Schumpeterian hypothesis have yielded such diverse results across industries. While it must be kept in mind that the results here only concern the firms in the Fortune 500 listings, it is also true that this range of firms is most relevant from the standpoint of antitrust policy.
IV. Summary and Conclusions
The main conclusion that emerges from the analysis is that interfirm differences in technology, product diversification, and availability of 20 The empirical results here would also be open to question if the propensity to patent were significantly correlated with firm size. By similar procedures to those discussed in the previous section, this was not indicated to be the case. See also discussion of this issue in Scherer (1965a, p. 1110-13) .
funds are all significant in explaining firm research intensity. The model presented here fits the two more research-oriented industries, chemicals and drugs, much better than petroleum refining. From a policy standpoint, these results indicate that the level of R & D expenditures will be sensitive to the broad class of government policy devices that affect the financial incentives confronting the firm. In particular, fiscal devices and other policy measures can be expected to influence the level of R & D expenditures through both profitability and flow of funds effects. Government policy actions directed toward stimulating growth should, therefore, be concerned with both of these effects if efficient programs are to be devised.
The major limitations of the present study arise from the substantial conceptual and empirical difficulties in measuring items such as R & D activity and its outputs. Considerable effort was therefore expended to obtain the best set of data that are currently available. While the results must be viewed as tentative, particularly because the total number of firms is small, they are nevertheless internally consistent and in general agreement with some of the past work in this area. They should, therefore, be of interest to economists and policy makers concerned with the economics of R & D.
